SUBMISSION DEADLINE: December 4, 2026
NOTIFICATION DATE: December 11, 2026
We invite all registered meeting attendees to submit abstracts for posters of their latest research on the following topics:
- Aesthetic Dermatology (Cosmeceuticals, Fillers and Neuromodulators, Laser and Energy Based Devices)
- Alopecia
- Inflammatory Skin Conditions (Acne, Rosacea, Atopic Dermatitis, Eczema, Psoriasis, Hidradenitis Suppurativa, Seborrheic Dermatitis, etc.)
- Pediatric Dermatology
- Pigmentary Disorders (Melasma, Vitiligo, Hyperpigmentation, Hypopigmentation, Photodamage, etc.) ;
- Skin Cancer
- Surgical Dermatology and Wound Healing
- Other Dermatologic Topics (Blistering Diseases, Granulomatous Diseases, Infectious Diseases, Keloids, Nail Disorders, etc.)
At least one (1) author must be registered for the in-person meeting to have their abstracts considered for poster display. All accepted abstracts will be displayed at the ODAC Dermatology Conference, January 15-18 2027, to be held at the Signia by Hilton Bonnet Creek, Orlando, Florida.
In addition, approved abstracts will also be submitted and indexed through our partner brand Read by QxMD. The platform drives awareness, dissemination, and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets, and any web-enabled device (including desktops), and uses channels such as mobile, email, and push notification to connect with our global community of healthcare providers and researchers.
Download the App:
If you are returning to complete or check the status of your submission, please sign-in (link sign-in to the main sign-in page of the abstract page and then delete this parentheses) using your email address and password.
Encore posters are welcome!
Fee: No fee for non-industry-sponsored abstracts; $495 per abstract for industry-sponsored abstracts.
At least one (1) author (or representative) must be registered for the in-person meeting to have their abstracts considered for poster display
Abstract Formatting and Content Guidelines
- Language: English
- Authors: full last name, first name, affiliations, degrees and contact information
- BOLD the name of the Presenting Author and include the Presenting Author's contact information
- Font: Arial
- Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations)
- Maximum of 2 relevant tables or figures submitted as attachments (not embedded in the file): must be 600 dpi .jpg
- Provide titles for each table and/or figure
- The author’s disclosures must be included to be accepted
- Reference citations must be included as superscripted numbers in order of appearance, corresponding to a numbered reference list at the end of the abstract
- Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email)
- Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, Conclusions, References (if appropriate), and Disclosures
- Abstracts containing non-generic drug names, personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted
Please note that abstracts will not be accepted if the presenting author’s name is not bolded, the presenting author’s email is not included and all authors’ disclosures are not listed.
If you have any questions, please contact MedscapeLIVE! at abstracts@medscapelive.com.